Page last updated: 2024-11-04

sumatriptan and Myasthenia Gravis

sumatriptan has been researched along with Myasthenia Gravis in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research Excerpts

ExcerptRelevanceReference
"Dihydroergotamine mesylate was also abortive in the few instances when the headache worsened."1.30Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications. ( Finkel, AG; Howard, JF; Mann, JD, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finkel, AG1
Howard, JF1
Mann, JD1

Other Studies

1 other study available for sumatriptan and Myasthenia Gravis

ArticleYear
Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
    Headache, 1998, Volume: 38, Issue:4

    Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache; Humans; Immunoglobulins, Intra

1998